Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Bolus Versus Infusion in High-Risk Patients Undergoing Elective Cesarean Section
NCT07688512Phase 4Not yet recruiting
- Sponsor
- Stony Brook University
- Start
- Aug 2026
- Primary completion
- Aug 2028
01
Overview
A Phase 4 trial of oxytocin in postpartum hemorrhage (PPH), uterine atony, sponsored by Stony Brook University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT07688512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07688512.